Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Buprenorphine Induction in Fentanyl Positive ED Patients
NCT05589181Phase 3Recruiting
- Sponsor
- Rutgers University
- Start
- Apr 2023
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of v1003 in opioid use disorder (OUD), sponsored by Rutgers University. Started Apr 2023; status: recruiting.
02
Drugs
v1003
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05589181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05589181.